Skip to content

Clinical trials

Phase 1 Diabetic Nephropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Phase: Phase 1 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20131
20141
20151
20161
20174
20192
20201
20214
20223
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting5
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Goldfinch Bio, Inc.2
Alebund Pharmaceuticals1
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Bayer1
Concert Pharmaceuticals1
Dong Wha Pharmaceutical Co. Ltd.1
Gilead Sciences1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies27
Renal Insufficiency, Chronic6
Diabetes Mellitus, Type 25
Diabetes Mellitus4
Proteinuria4
Diabetes Complications3
Diabetes Mellitus, Type 13
Endocrine System Diseases2
Glomerulosclerosis, Focal Segmental2
Kidney Diseases2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.